Skip to content

Marc Aixalà

9 papers in the library · 182 citations · publishing 2017-2025

Papers

Sort Most recent Most cited

An international Delphi consensus for reporting of setting in psychedelic clinical trials.

Nature Medicine June 3, 2025 Chloé Pronovost-Morgan, Kyle T. Greenway, Leor Roseman et al. 26 citations

Psychedelic substances exhibit complex interactions with the 'set and setting' of use, that is, the mental state of the user and the environment in which a psychedelic experience takes place. Despite these contextual variables' known importance, psychedelic research has lacked methodological rigor in reporting extra-pharmacological factors. This study aimed to generate consensus-based...

On Minimizing Risk and Harm in the Use of Psychedelics.

Psychiatr Res Clin Pract February 11, 2025 Jules Evans, Marc Aixalà, Brian T Anderson et al. 18 citations

Objective: This article outlines recommendations from 30 psychedelic researchers on how to create a better psychedelic safety net. Methods: A survey of 30 psychedelic researchers asked them to identify key critical research gaps around psychedelic harm and safety. Results: The critical research gaps identified by the authors included defining the main types of psychedelic harm, the predictors...

Call for evidence-based psychedelic integration.

Experimental and Clinical Psychopharmacology November 27, 2023 Jakub Greń, Ingmar Gorman, Anastasia Ruban et al. 27 citations

The use of psychedelics for various purposes was common in different civilizations throughout human history and has been explored scientifically for more than a century. Although the applications of psychedelics show promise in the treatment of various psychiatric and neurological indications, as well as in facilitation of well-being and personal growth, several psychedelic-related risks and...

Restorative Retelling for Processing Psychedelic Experiences: Rationale and Case Study of Complicated Grief

Frontiers in Psychology May 3, 2022 Débora González, Marc Aixalà, Robert A Neimeyer et al. 15 citations

Rationale Many psychedelic experiences are meaningful, but ineffable. Engaging in meaning-making regarding emerging symbolic content and changing previous schemas have been proposed as mechanisms of change in psychedelic therapy. Objective Firstly, we suggest the implementation of a Restorative Retelling (RR) technique to process and integrate the psychedelic experience into autobiographical...

Patterns of use, desired effects, and mental health status of a sample of natural psychoactive drug users

Drugs Education Prevention and Policy May 7, 2019 Marc Aixalà, Genís Ona, Òscar Parés et al. 16 citations

In recent years, the use of natural psychoactive drugs (NPDs) has grown rapidly. They are classified as new psychoactive substances (NPSs), despite the reality that they have been used for centuries. We are lacking information regarding patterns of use or characteristics of users, but some evidence suggests that NPDs substantially differ from NPSs in terms of both their safety profile and...

Psychedelics and Personality

ACS Chemical Neuroscience June 4, 2018 Marc Aixalà, Rafael G. Dos Santos, Jaime E. C. Hallak et al. 14 citations

In the past decade, an increasing number of clinical trials are reporting evidence that psychedelics or serotonergic hallucinogens (such as lysergic acid diethylamide, psilocybin, and ayahuasca/dimethyltryptamine) could be effective in the treatment of mood, anxiety, and substance use disorders. The mechanisms responsible for these effects are not fully understood but seem to involve changes in...

Potential Use of Ayahuasca in Grief Therapy

OMEGA - Journal of Death and Dying May 30, 2017 Débora González, Maria Carmo Carvalho, Jordi Cantillo et al. 43 citations

The death of a loved one is ultimately a universal experience. However, conventional interventions employed for people suffering with uncomplicated grief have gathered little empirical support. The present study aimed to explore the potential effects of ayahuasca on grief. We compared 30 people who had taken ayahuasca with 30 people who had attended peer-support groups, measuring level of grief...

Detoxification from methadone using low, repeated, and increasing doses of ibogaine: A case report

Journal of Psychedelic Studies April 1, 2017 Clare Wilkins, Rafael G. Dos Santos, Jordi Solà et al. 15 citations

Ibogaine is a natural alkaloid that has been used in the last decades as an adjuvant for the treatment of opiate withdrawal. Despite the beneficial results suggested by animal studies and case series, there is a lack of clinical trials to assess the safety and efficacy of ibogaine. Moreover, the majority of reports described cases of heroin-dependent individuals, with and without concomitant...